enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
3.060
-0.230 (-6.99%)
At close: Jun 20, 2025, 4:00 PM
3.150
+0.090 (2.94%)
After-hours: Jun 20, 2025, 4:00 PM EDT
enGene Holdings Employees
As of October 31, 2024, enGene Holdings had 57 total employees, including 56 full-time and 1 part-time employees. The number of employees increased by 24 or 72.73% compared to the previous year.
Employees
57
Change (1Y)
24
Growth (1Y)
72.73%
Revenue / Employee
n/a
Profits / Employee
-$1,401,368
Market Cap
160.98M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 57 | 24 | 72.73% |
Oct 31, 2023 | 33 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ENGN News
- 2 days ago - enGene Holdings: Looking For An End To The 2025 Decline (Downgrade) - Seeking Alpha
- 3 days ago - enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 8 days ago - enGene Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 16 days ago - enGene Announces the Resignation of its Chief Medical Officer - Business Wire
- 22 days ago - enGene to Present at the Jefferies Global Healthcare Conference - Business Wire
- 23 days ago - enGene Names Amy Pott as Chief Global Commercialization Officer - Business Wire
- 7 weeks ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum - Business Wire